Estimation of plasma small dense LDL cholesterol from classic lipid measures

American Journal of Clinical Pathology

Volumn 136, Issue 1, 2011, Pages 20-29

  Srisawasdi, Pornpen ^a   Chaloeysup, Sirirat ^a   Teerajetgul, Yaovalak ^b   Pocathikorn, Anothai ^c   Sukasem, Chonlaphat ^a   Vanavanan, Somlak ^a   Kroll, Martin H ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Homogeneous assay; Lipoprotein subfraction; Low density lipoprotein cholesterol; Metabolic syndrome; Non high density lipoprotein cholesterol; Small, dense low density lipoprotein cholesterol

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SMALL DENSE LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; KIDNEY DISEASE; LIPID ANALYSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 79960126157     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPLHJBGG9L3ILS     Document Type: Article

References (36)

1. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
2. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004;109:2-7.
3. Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small low density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006;113:20-29. (Pubitemid 43958484)
4. Rizzo M, Berneis K. Low-density-lipoprotein size and cardiovascular risk assessment [published correction appears in QJM. 2007;100:147]. QJM. 2006;99:1-14.
5. St-Pierre AC. Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men, 13-year follow-up data from the Quebec cardiovascular study. Arterioscler Thromb Vasc Biol. 2005;25:553-559. (Pubitemid 40315677)
6. Rizzo M, Pernice V, Frasheri A, et al. Small, dense low-density lipoproteins are predictors of cardio- and cerebrovascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf). 2009;70:870-875.
7. Zeljkovic A, Vekic J, Kalimanovska VS, et al. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis. 2010;210:548-554.
8. Myers GL, ed. Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke. Washington, DC: The National Academy of Clinical Biochemistry; 2009.
9. Ginsberg HN, Zhang Y, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36:232-240. (Pubitemid 40755136)
10. Adiels M, Olofsson S, Taskinen M, et al. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225-1236.
11. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009;42:1331-1346.
12. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta. 2006;368:1-19. (Pubitemid 43776015)
13. Grundy SM, Brewer HB Jr, Cleeman JJ, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438.
14. Griffin BA, Caslake MJ, Yip B, et al. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 1990;83:59-67. (Pubitemid 20210746)
15. Alabakovska SB, Todorova BB, Labudovic DD, et al. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians. Clin Chim Acta. 2002;317:119-123. (Pubitemid 34114026)
16. Hoefner DM, Hodel SD, O'Brien JF, et al. Development of a rapid quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL system. Clin Chem. 2001;47:266-274. (Pubitemid 32142925)
17. Kuller L, Arnold A, Tracy R, et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2002;22:1175-1180. (Pubitemid 34764870)
18. Ito Y, Fujimura M, Ohta M, et al. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem. 2011;57:57-65.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
20. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002;48:236-254. (Pubitemid 34107260)
21. Miller WG, Waymack PP, Anderson FP, et al. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem. 2002;48:489-498. (Pubitemid 34174579)
22. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus [published correction appears in Diabetes Care. 2010;33:e57]. Diabetes Care. 2010;33(suppl 1):S62-S69.
24. National Institutes of Health. Recommendations for Improving Cholesterol Measurement: A Report From the Laboratory Standardization Panel of the National Cholesterol Education Program. Bethesda, MD: National Institutes of Health; 1990. NIH publication 90-2964.
25. Akosah KO, Schaper A, Cogbill C, et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475-1479.
26. Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab. 1999;25:199-211. (Pubitemid 29426371)
27. Koba S, Hirano T, Kondo T, et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart diseases. Am Heart J. 2002;144:1026-1035. (Pubitemid 36026916)
28. St-Pierre AC, Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25:553-559. (Pubitemid 40315677)
29. Koba S, Hirano T, Ito Y, et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;189:206-214. (Pubitemid 44441285)
30. Tokuno A, Hirano T, Hayashi T, et al. The effects of statin and fibrate on lowering small dense LDL-cholesterol in hyperlipidemic patients with type 2 diabetes. J Atheroscler Thromb. 2007;14:128-132.
31. Ensign W, Hill N, Heward CB. Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. Clin Chem. 2006;52:1722-1727. (Pubitemid 44330706)
32. Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993-2000.
33. Cui Y, Blumenthal R, Flaws J, et al. Non-high-density lipoprotein cholesterol level as predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413-1419. (Pubitemid 32681162)
34. Miller M, Ginsberg HN, Schaefer EJ. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease. Am J Cardiol. 2008;101:1003-1008.
35. Kramer MA. Focus on Cholesterol Research. New York, NY: Nova Science Publishers; 2005:113-146.
36. Miller WG, Myers GL, Sakurabayashi I, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem. 2010;56:977-986.